يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Ferraccioli, Gianfranco"', وقت الاستعلام: 0.96s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA

    المؤلفون: Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Sebastiani, Marco, Panetta, Valentina, Salaffi, Fausto, Iannone, Florenzo, Carletto, Antonio, Foti, Rosario, Gremese, Elisa, Govoni, Marcello, Marchesoni, Antonio, Favalli, Ennio, Gorla, Roberto, Ramonda, Roberta, Ferraccioli, Gianfranco, Lapadula, Giovanni

    المساهمون: Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Sebastiani, Marco, Panetta, Valentina, Salaffi, Fausto, Iannone, Florenzo, Carletto, Antonio, Foti, Rosario, Gremese, Elisa, Govoni, Marcello, Marchesoni, Antonio, Favalli, Ennio, Gorla, Roberto, Ramonda, Roberta, Ferraccioli, Gianfranco, Lapadula, Giovanni

    مصطلحات موضوعية: Adalimumab, Adult, Antirheumatic Agent, Etanercept, Female, Human, Infection, Infliximab, Italy, Male, Middle Aged, Registrie, Spondylarthropathie, Surveys and Questionnaire, Tumor Necrosis Factor-alpha

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30767865; info:eu-repo/semantics/altIdentifier/wos/WOS:000473242000017; volume:37; issue:4; firstpage:649; lastpage:655; numberofpages:7; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11577/3308919Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85069269152

    الإتاحة: http://hdl.handle.net/11577/3308919Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA

    المؤلفون: Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Sebastiani, Marco, Panetta, Valentina, Salaffi, Fausto, Iannone, Florenzo, Carletto, Antonio, Foti, Rosario, Gremese, Elisa, Govoni, Marcello, Marchesoni, Antonio, Favalli, Ennio, Gorla, Roberto, Ramonda, Roberta, Ferraccioli, Gianfranco, Lapadula, Giovanni

    المساهمون: Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Sebastiani, Marco, Panetta, Valentina, Salaffi, Fausto, Iannone, Florenzo, Carletto, Antonio, Foti, Rosario, Gremese, Elisa, Govoni, Marcello, Marchesoni, Antonio, Favalli, Ennio, Gorla, Roberto, Ramonda, Roberta, Ferraccioli, Gianfranco, Lapadula, Giovanni

    مصطلحات موضوعية: Adalimumab, Adult, Antirheumatic Agent, Etanercept, Female, Human, Infection, Infliximab, Italy, Male, Middle Aged, Registrie, Spondylarthropathie, Surveys and Questionnaire, Tumor Necrosis Factor-alpha

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30767865; info:eu-repo/semantics/altIdentifier/wos/WOS:000473242000017; volume:37; issue:4; firstpage:649; lastpage:655; numberofpages:7; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11570/3151497Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85069269152

    الإتاحة: http://hdl.handle.net/11570/3151497Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)

    المؤلفون: IANNONE, Florenzo, LAPADULA, Giovanni, Ferraccioli, Gianfranco, Gremese, Elisa

    المساهمون: Iannone, Florenzo, Ferraccioli, Gianfranco, Gremese, Elisa, Lapadula, Giovanni

    مصطلحات موضوعية: Anti-TNF, Rheumatoid Arthriti, TNF-alpha, Adalimumab, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthritis, Rheumatoid, Etanercept, Human, Immunoglobulin G, Infliximab, Medication Adherence, Receptors, Tumor Necrosis Factor, Tumor Necrosis Factor-alpha, Rheumatology, Immunology, Biochemistry, Genetics and Molecular Biology (all), Immunology and Allergy

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000335362100002; volume:73; issue:6; firstpage:e31; lastpage:e31; journal:ANNALS OF THE RHEUMATIC DISEASES; http://hdl.handle.net/11586/146506Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84899917627; http://ard.bmj.com/content/73/6/e31.full.pdf+htmlTest

    الإتاحة: https://doi.org/10.1136/annrheumdis-2013-205011Test
    http://hdl.handle.net/11586/146506Test
    http://ard.bmj.com/content/73/6/e31.full.pdf+htmlTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine

    المؤلفون: Gremese, Elisa, Carletto, Antonio, Padovan, Melissa, Atzeni, Fabiola, Raffeiner, Bernd, Giardina, Anna Rita, Favalli, Ennio Giulio, Erre, Gian Luca, Gorla, Roberto, Galeazzi, Mauro, Foti, Rosario, Cantini, Fabrizio, Salvarani, Carlo, Olivieri, Ignazio, Lapadula, Giovanni, Ferraccioli, Gianfranco

    المساهمون: Gremese, Elisa, Carletto, Antonio, Padovan, Melissa, Atzeni, Fabiola, Raffeiner, Bernd, Giardina, Anna Rita, Favalli, Ennio Giulio, Erre, Gian Luca, Gorla, Roberto, Galeazzi, Mauro, Foti, Rosario, Cantini, Fabrizio, Salvarani, Carlo, Olivieri, Ignazio, Lapadula, Giovanni, Ferraccioli, Gianfranco

    مصطلحات موضوعية: Adalimumab, Aged, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthritis, Rheumatoid, Dose-Response Relationship, Drug, Etanercept, Female, Human, Immunoglobulin G, Infliximab, Longitudinal Studie, Male, Middle Aged, Obesity, Precision Medicine, Receptors, Tumor Necrosis Factor, Registrie, Remission Induction, Treatment Outcome, Tumor Necrosis Factor-alpha

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22730143; info:eu-repo/semantics/altIdentifier/wos/WOS:000312939700013; volume:65; issue:1; firstpage:94-100; lastpage:100; journal:ARTHRITIS CARE & RESEARCH; http://hdl.handle.net/11570/3125384Test

    الإتاحة: https://doi.org/10.1002/acr.21768Test
    http://hdl.handle.net/11570/3125384Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine

    المؤلفون: Gremese, Elisa, Carletto, Antonio, Padovan, Melissa, Atzeni, Fabiola, Raffeiner, Bernd, Giardina, Anna Rita, Favalli, Ennio Giulio, Erre, Gian Luca, Gorla, Roberto, Galeazzi, Mauro, Foti, Rosario, Cantini, Fabrizio, Salvarani, Carlo, Olivieri, Ignazio, LAPADULA, Giovanni, Ferraccioli, Gianfranco

    المساهمون: Gremese, Elisa, Carletto, Antonio, Padovan, Melissa, Atzeni, Fabiola, Raffeiner, Bernd, Giardina, Anna Rita, Favalli, Ennio Giulio, Erre, Gian Luca, Gorla, Roberto, Galeazzi, Mauro, Foti, Rosario, Cantini, Fabrizio, Salvarani, Carlo, Olivieri, Ignazio, Lapadula, Giovanni, Ferraccioli, Gianfranco

    مصطلحات موضوعية: Adalimumab, Aged, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthritis, Rheumatoid, Dose-Response Relationship, Drug, Etanercept, Female, Human, Immunoglobulin G, Infliximab, Longitudinal Studie, Male, Middle Aged, Obesity, Precision Medicine, Receptors, Tumor Necrosis Factor, Registrie, Remission Induction, Treatment Outcome, Tumor Necrosis Factor-alpha, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000312939700013; volume:65; issue:1; firstpage:94; lastpage:100; numberofpages:7; journal:ARTHRITIS CARE & RESEARCH; http://hdl.handle.net/11586/150739Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84871821443

    الإتاحة: https://doi.org/10.1002/acr.21768Test
    http://hdl.handle.net/11586/150739Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

    المؤلفون: Atzeni, Fabiola, Sarzi Puttini, Piercarlo, Botsios, Costantino, Cipriani, Paola, Favalli, Ennio Giulio, Frati, Elena, Foschi, Valentina, Gasparini, Stefania, Giardina, Annarita, Gremese, Elisa, Iannone, Florenzo, Sebastiani, Marco, Ziglioli, Tamara, Ferri, Clodoveo, Galeazzi, Mauro, Gerli, Roberto, Giacomelli, Roberto, Gorla, Roberto, Govoni, Marcello, Lapadula, Giovanni, Marchesoni, Antonio, Salaffi, Fausto, Punzi, Leonardo, Triolo, Giovanni, Ferraccioli, Gianfranco, Carletto, Antonio, BIASI, Domenico

    المساهمون: Atzeni, Fabiola, Sarzi Puttini, Piercarlo, Botsios, Costantino, Carletto, Antonio, Cipriani, Paola, Favalli, Ennio Giulio, Frati, Elena, Foschi, Valentina, Gasparini, Stefania, Giardina, Annarita, Gremese, Elisa, Iannone, Florenzo, Sebastiani, Marco, Ziglioli, Tamara, Biasi, Domenico, Ferri, Clodoveo, Galeazzi, Mauro, Gerli, Roberto, Giacomelli, Roberto, Gorla, Roberto, Govoni, Marcello, Lapadula, Giovanni, Marchesoni, Antonio, Salaffi, Fausto, Punzi, Leonardo, Triolo, Giovanni, Ferraccioli, Gianfranco

    مصطلحات موضوعية: Adalimumab, Adult, Aged, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthritis, Rheumatoid, Etanercept, Female, Human, Immunoglobulin G, Incidence, Infection, Infliximab, Male, Middle Aged, Receptors, Tumor Necrosis Factor, Registrie, Tumor Necrosis Factors

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22796281; info:eu-repo/semantics/altIdentifier/wos/000313403500019; volume:12; issue:2; firstpage:225; lastpage:229; numberofpages:5; journal:AUTOIMMUNITY REVIEWS; http://hdl.handle.net/11562/933166Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84870253476

    الإتاحة: https://doi.org/10.1016/j.autrev.2012.06.008Test
    http://hdl.handle.net/11562/933166Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Longterm retention of tumor necrosis factor-α inhibitor therapy in a large Italian cohort of patients with rheumatoid arthritis from the GISEA Registry: An appraisal of predictors

    المؤلفون: Iannone, Florenzo, Gremese, Elisa, Atzeni, Fabiola, Biasi, Domenico, Botsios, Costantino, Cipriani, Paola, Ferri, Clodoveo, Foschi, Valentina, Galeazzi, Mauro, Gerli, Roberto, Giardina, Annarita, Marchesoni, Antonio, Salaffi, Fausto, Ziglioli, Tamara, Lapadula, Giovanni, Bambara, Maria Lisa, Cantini, Fabrizio, Ferraccioli, Gianfranco, Foti, Rosario, Giacomelli, Roberto, Gorla, Roberto, Grassi, Walter, Mathieu, Alessandro, Olivieri, Ignazio, Passiu, Giuseppe, Punzi, Leonardo, Salvarani, Carlo, Sarzi-Puttini, Piercarlo, Scarpa, Raffaele, Triolo, Giovanni, Trotta, Francesco

    المساهمون: Iannone, Florenzo, Gremese, Elisa, Atzeni, Fabiola, Biasi, Domenico, Botsios, Costantino, Cipriani, Paola, Ferri, Clodoveo, Foschi, Valentina, Galeazzi, Mauro, Gerli, Roberto, Giardina, Annarita, Marchesoni, Antonio, Salaffi, Fausto, Ziglioli, Tamara, Lapadula, Giovanni, Bambara, Maria Lisa, Cantini, Fabrizio, Ferraccioli, Gianfranco, Foti, Rosario, Giacomelli, Roberto, Gorla, Roberto, Grassi, Walter, Mathieu, Alessandro, Olivieri, Ignazio, Passiu, Giuseppe, Punzi, Leonardo, Salvarani, Carlo, Sarzi-Puttini, Piercarlo, Scarpa, Raffaele, Triolo, Giovanni, Trotta, Francesco

    مصطلحات موضوعية: Adalimumab, Drug survival, Etanercept, Infliximab, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthralgia, Arthritis, Rheumatoid, Biomarker, Drug Substitution, Female, Health Statu, Human, Immunoglobulin G, Italy, Joint, Kaplan-Meier Estimate, Male, Middle Aged, Pain Measurement, Prospective Studie, Receptors, Tumor Necrosis Factor, Survival Rate, Time Factor, Tumor Necrosis Factor-alpha, Registrie

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22467933; info:eu-repo/semantics/altIdentifier/wos/WOS:000304893800014; volume:39; issue:6; firstpage:1179; lastpage:1184; numberofpages:6; journal:THE JOURNAL OF RHEUMATOLOGY; http://hdl.handle.net/11570/3125362Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84861811932; http://www.jrheum.org/content/39/6/1179.full.pdf+htmlTest

    الإتاحة: https://doi.org/10.3899/jrheum.111125Test
    http://hdl.handle.net/11570/3125362Test
    http://www.jrheum.org/content/39/6/1179.full.pdf+htmlTest

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

    المؤلفون: Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Botsios, Costantino, Carletto, Antonio, Cipriani, Paola, Favalli, Ennio Giulio, Frati, Elena, Foschi, Valentina, Gasparini, Stefania, Giardina, AnnaRita, Gremese, Elisa, Iannone, Florenzo, Sebastiani, Marco, Ziglioli, Tamara, Biasi, Domenico, Ferri, Clodoveo, Galeazzi, Mauro, Gerli, Roberto, Giacomelli, Roberto, Gorla, Roberto, Govoni, Marcello, Lapadula, Giovanni, Marchesoni, Antonio, Salaffi, Fausto, Punzi, Leonardo, Triolo, Giovanni, Ferraccioli, Gianfranco

    المساهمون: Atzeni, Fabiola, Sarzi-Puttini, Piercarlo, Botsios, Costantino, Carletto, Antonio, Cipriani, Paola, Favalli, Ennio Giulio, Frati, Elena, Foschi, Valentina, Gasparini, Stefania, Giardina, Annarita, Gremese, Elisa, Iannone, Florenzo, Sebastiani, Marco, Ziglioli, Tamara, Biasi, Domenico, Ferri, Clodoveo, Galeazzi, Mauro, Gerli, Roberto, Giacomelli, Roberto, Gorla, Roberto, Govoni, Marcello, Lapadula, Giovanni, Marchesoni, Antonio, Salaffi, Fausto, Punzi, Leonardo, Triolo, Giovanni, Ferraccioli, Gianfranco

    مصطلحات موضوعية: GISEA register, Infection, Anti-TNF agent, Predictive factor, Adalimumab, Adult, Aged, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthritis, Rheumatoid, Etanercept, Female, Human, Immunoglobulin G, Incidence, Infliximab, Male, Middle Aged, Receptors, Tumor Necrosis Factor, Registrie, Tumor Necrosis Factors

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22796281; info:eu-repo/semantics/altIdentifier/wos/WOS:000313403500019; volume:12; issue:2; firstpage:225; lastpage:229; numberofpages:5; journal:AUTOIMMUNITY REVIEWS; http://hdl.handle.net/11570/3125290Test

    الإتاحة: https://doi.org/10.1016/j.autrev.2012.06.008Test
    http://hdl.handle.net/11570/3125290Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث